D-0363-2024 Class II Ongoing
FDA drug recall D-0363-2024 was initiated by Denver Solutions, LLC DBA Leiters Health on Feb 20, 2024 and is designated Class II. Reason for recall: Presence of Particulate Matter: glass vials from the manufacturer showed signs of glass delamination. The recall status is ongoing. Affected quantity: 40,890 vials.
Recall details
- Product Type
- Drugs
- Report Date
- Mar 6, 2024
- Initiation Date
- Feb 20, 2024
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 40,890 vials
Product description
Lidocaine HCL 1% (10mg/mL), PHENYLephrine HCL 1.5% (15mg/mL), 1 ml in a Single- Dose Vial, RX Only, Leiters 13796 Compark Blvd, Englewood, CO 80112, NDC 71449-090-42
Reason for recall
Presence of Particulate Matter: glass vials from the manufacturer showed signs of glass delamination.
Distribution pattern
Nationwide in the USA
Code information
Lot #:2331104, Exp:9-Mar-24; 2331137, Exp: 3-Mar-24; 2331196, Exp: 11-Mar-24; 2331264, Exp: 6-Apr-24; 2331282, Exp: 18-Apr-24; 2331464, Exp: 8-May-24; 2331481, Exp: 16-May-24; 2331500, Exp: 20-May-24.
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0363-2024
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026